Dr. Jonathan Javitt, CEO of NRx Pharmaceuticals, and Anne Dunsmore, Founder of Angel Force USA, discuss their joint mission to prevent veteran suicide through advanced neuroplastic therapies and nationwide awareness programs.
Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals, presents at Noble Capital Markets Virtual Emerging Growth Conference.
Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
AdvisorShares is an institutional investor and holder of NRXP stock.
Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
AdvisorShares is an institutional investor and holder of NRXP stock.
Interview discusses NRx Pharmaceuticals’ game-changing approach to mental health treatment.
Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
AdvisorShares is an institutional investor and holder of NRXP stock.
Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
AdvisorShares is an institutional investor and holder of NRXP stock.
The Big Biz Show interviews Jonathan C. Javitt, M.D., M.P.H. Founder, Chairman and CEO of NRx Pharmaceuticals and Co-CEO of HOPE Therapeutics discussing applications of Ketamine and it’s treatment for acute suicidality, anti-depressant/chronic pain oral medication NRX-101, how dopamine acts as a neurotransmitter in the brain and the recent investor workshop at the Mar-A-Lago Club.
The Big Biz Show interviews Jonathan C. Javitt, M.D., M.P.H. Founder, Chairman and CEO of NRx Pharmaceuticals and Co-CEO of HOPE Therapeutics, discussing the opportunity for HOPE Therapeutics in developing its nationwide network of interventional psychiatry clinics to help address the national epidemic of suicidality and mental health, the planned financing and upcoming presentations by management in San Francisco and at Mar-A-Lago.
